<p>Dry Eye Disease (DED) is a condition characterized by insufficient lubrication and moisture on the surface of the eye, leading to irritation, inflammation, and discomfort. It can result from reduced tear production or poor tear quality and can cause symptoms like dryness, burning, and visual disturbances. DED is often linked to environmental factors, aging, autoimmune diseases, and certain medications.</p>
<h2><strong>Dry Eye Disease Epidemiological Segmentation</strong></h2>
<p>The Epidemiological Segmentation of Dry Eye Disease (DED) in the 7MM (United States, EU5&mdash;Germany, France, Italy, Spain, and the United Kingdom&mdash;and Japan) from 2023 to 2034 includes:</p>
<ul>
<li>Total Diagnosed Prevalent Cases of DED</li>
<li>Gender-specific Diagnosed Prevalent Cases of DED</li>
<li>Age-specific Diagnosed Prevalent Cases of DED</li>
<li>Severity-specific Diagnosed Prevalent Cases of DED</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/dry-eye-disease-epidemiology-forecast"><span style="text-decoration: underline;"><strong>Dry Eye Disease Epidemiology</strong></span></a></h2>
<ul>
<li>In 2023, the total diagnosed prevalent cases of Dry Eye Disease (DED) across the 7MM were estimated at approximately 54,695 thousand.</li>
<li>Among the European countries, the United Kingdom had the highest diagnosed prevalent cases of DED with around 6,112 thousand cases, followed by Germany with approximately 5,004 thousand cases in 2023. Spain had the lowest prevalence at about 2,064 thousand cases.</li>
<li>The US had the highest number of total diagnosed prevalent cases of DED among the 7MM, accounting for 41% of the cases, while Japan had the least at 19%. This trend is expected to persist during the forecast period.</li>
<li>In the US, gender-specific diagnosed prevalent cases revealed 9,439 thousand cases among males and approximately 13,035 thousand cases among females. By 2034, the prevalence among females is expected to surpass that of males.</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/dry-eye-disease-market-insights"><span style="text-decoration: underline;"><strong>Dry Eye Disease Market</strong></span></a></h2>
<p>The market size for Dry Eye Disease (DED) in the US was the highest among the 7MM, amounting to approximately USD 2,739 million in 2023. This market size is projected to grow significantly by 2034.</p>
<h2>Dry Eye Disease Market Drivers</h2>
<ul>
<li>Increased Diagnosis: As diagnostic awareness improves, more patients will be diagnosed, which will contribute to the expansion of the market.</li>
<li>Aging Population: With the increasing aging population, the number of individuals susceptible to DED will rise, further contributing to the market's growth.</li>
</ul>
<h2>Dry Eye Disease Market Barriers</h2>
<ul>
<li>Limited Treatment Options: The availability of effective disease-modifying therapies remains limited, hindering comprehensive management of DED.</li>
<li>High Treatment Costs: The high costs of diagnosis and long-term management may limit patient access to appropriate care, especially in lower-income populations.</li>
</ul>
<h2><a href="https://www.delveinsight.com/report-store/dry-eye-disease-pipeline-insight"><span style="text-decoration: underline;"><strong>Dry Eye Disease Emerging Therapies</strong></span></a></h2>
<ul>
<li>RGN-259</li>
<li>Tavilermide</li>
<li>AR-15512</li>
</ul>
<p>and others.</p>
<h2><strong>Dry Eye Disease Key Players</strong></h2>
<ul>
<li>Palatin Technologies, Inc.</li>
<li>Aldeyra Therapeutics, Inc.</li>
<li>ReGenTree/RegeneRx Biopharmaceuticals, Inc.</li>
<li>Mimetogen</li>
<li>Alcon/Aerie Pharmaceuticals</li>
<li>BRIM Biotechnology, Inc.</li>
<li>Seikagaku Corporation</li>
<li>Mitotech</li>
<li>Senju Pharmaceutical</li>
<li>Sylentis, S.A./PharmaMar</li>
<li>Stuart Therapeutics</li>
<li>VivaVision Biotech</li>
<li>HanAll BioPharma Co., Ltd./Daewoong Pharmaceutical Co. Ltd.</li>
<li>Redwood Pharma AB</li>
<li>AxeroVision, Inc.</li>
<li>OKYO Pharma</li>
<li>Glaukos Corporation</li>
<li>Oculis</li>
</ul>
<p>And others.</p>

Dry Eye Disease Market Infographic

Dry Eye Disease Market Symptoms, Treatment, epidemiology, companies, drugs infographic is a short guide to understand the problem and market landscape.